News by region
The NHS’s first prostate cancer screening programme could receive approval this week from the government’s National Screening Committee. The National Screening Committee (NSC) meets on Thursday to decide whether to introduce wider screening to detect disease earlier. Any rollout would likely focus on those at highest risk, including people with a family history or specific [...]
Scotland has set out a life sciences strategy aimed at growing the sector to £25bn by 2035. The Scottish Government’s refreshed Life Sciences Strategy focuses on infrastructure and skills, and brings in technologies such as artificial intelligence. An initial £1m will support delivery. Business minister Richard Lochhead, who launched the strategy at Dundee [...]
Macmillan Cancer Support and Life Sciences Hub Wales have joined forces to accelerate the pace of innovation in cancer care and improve outcomes for people affected by cancer across Wales. During its initial discovery phase, the new partnership will engage a broad group of core delivery and advisory partners, including people with a lived experience [...]
As men’s health moves from a relatively niche category to a well-capitalised, innovation-driven market, it's a sector gaining momentum. According to data from FounderNest, an AI-powered market intelligence platform, digital diagnostics, mental health platforms, fertility solutions, and preventative care technologies are attracting significant investment and scaling rapidly. These innovations are collectively shaping the next generation [...]
A new report from System C, ‘AI with Purpose: Insights from 300 Voices Shaping the Future of Health and Social Care,’ reveals a strong appetite for artificial intelligence across the NHS and wider healthcare sector – with the majority of respondents agreeing that AI can help streamline tasks and improve care delivery. The findings, published [...]
By McDermott Will & Schulte European life sciences businesses have been closely tracking geopolitics and global policy changes over the past 12 months, particularly as the new administration in the United States heightens its focus on drug pricing. Against this backdrop, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will [...]
New pinprick blood tests could detect early signs of disease more than 10 years before symptoms appear, following analysis of samples from 500,000 people. The tests are being developed after researchers completed measurements of nearly 250 different proteins, sugars, fats and other compounds in blood collected from half a million volunteers. These molecular profiles provide [...]
Global markets rose after Nvidia posted third-quarter earnings that exceeded Wall Street estimates, easing concerns about AI sector valuations. The chipmaker reported US$1.30 in diluted earnings per share on US$57.01bn in total revenues, beating investor expectations of US$1.26 on US$54.9bn. Sales increased 62 per cent year on year. Nvidia, the world's most valuable [...]
A new TB treatment called sorfequiline has shown stronger action against the bacteria than existing drugs in early-stage trial results. The antibiotic demonstrated what researchers describe as enhanced effectiveness against TB bacteria with a comparable safety profile to current treatments. The findings could lead to shorter treatment times and improved cure rates for a disease [...]
Holly Health, in collaboration with Loughborough University and Modality Partnership, has completed an Innovate UK–funded 18-month project focused on advancing digital self-management for people living with or at risk of multimorbidity. By combining behavioural science with machine learning technology within the Holly Health app, the Biomedical Catalyst project introduced a just-in-time adaptive intervention (JITAI) system. [...]
